Cargando…
SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1
Suppression of tissue inhibitor of matrix metalloproteinase (TIMP) is associated with the tumor-like invasion of fibroblast-like synoviocytes (FLSs) that occurs during rheumatoid arthritis-related cartilage destruction. Silent information regulator 2 homolog1 (SIRT1), a histone deacetylase, is widel...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687661/ https://www.ncbi.nlm.nih.gov/pubmed/29179491 http://dx.doi.org/10.18632/oncotarget.21628 |
_version_ | 1783279003170242560 |
---|---|
author | Guo, Jiangtao Zhao, Wei Cao, Xuqing Yang, Huiying Ding, Juan Ding, Jingbin Tan, Zifang Ma, Xiaoli Hao, Chunfang Wu, Lili Ma, Zhengjuan Xie, Jianjun Wang, Zhijun |
author_facet | Guo, Jiangtao Zhao, Wei Cao, Xuqing Yang, Huiying Ding, Juan Ding, Jingbin Tan, Zifang Ma, Xiaoli Hao, Chunfang Wu, Lili Ma, Zhengjuan Xie, Jianjun Wang, Zhijun |
author_sort | Guo, Jiangtao |
collection | PubMed |
description | Suppression of tissue inhibitor of matrix metalloproteinase (TIMP) is associated with the tumor-like invasion of fibroblast-like synoviocytes (FLSs) that occurs during rheumatoid arthritis-related cartilage destruction. Silent information regulator 2 homolog1 (SIRT1), a histone deacetylase, is widely involved in transcriptional regulation, genomic stability, metabolism and DNA repair. Recent studies suggest that SIRT1 may also impact inflammatory response and the proliferation of FLSs in rheumatoid arthritis (RA). However, it is unknown whether SIRT1 has a role in the tumor-like invasion of FLSs in rheumatoid arthritis. Herein we report that SIRT1 contributes to FLS invasion and cartilage destruction via a TIMP1-dependent mechanism. Elevated SIRT1 in RA synovia suppresses TIMP1 expression via deacetylation of TIMP1-associated histones, thereby disrupting the binding of the transcription factor specificity protein 1 (Sp1) to the TIMP1 promoter. In rats with collagen-induced arthritis, depletion of SIRT1 remarkably promoted TIMP1 expression in synovial tissues and ameliorated cartilage destruction. These results describe a new role for SIRT1 and demonstrate its potential value as a therapeutic target for rheumatoid arthritis. |
format | Online Article Text |
id | pubmed-5687661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56876612017-11-20 SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1 Guo, Jiangtao Zhao, Wei Cao, Xuqing Yang, Huiying Ding, Juan Ding, Jingbin Tan, Zifang Ma, Xiaoli Hao, Chunfang Wu, Lili Ma, Zhengjuan Xie, Jianjun Wang, Zhijun Oncotarget Research Paper Suppression of tissue inhibitor of matrix metalloproteinase (TIMP) is associated with the tumor-like invasion of fibroblast-like synoviocytes (FLSs) that occurs during rheumatoid arthritis-related cartilage destruction. Silent information regulator 2 homolog1 (SIRT1), a histone deacetylase, is widely involved in transcriptional regulation, genomic stability, metabolism and DNA repair. Recent studies suggest that SIRT1 may also impact inflammatory response and the proliferation of FLSs in rheumatoid arthritis (RA). However, it is unknown whether SIRT1 has a role in the tumor-like invasion of FLSs in rheumatoid arthritis. Herein we report that SIRT1 contributes to FLS invasion and cartilage destruction via a TIMP1-dependent mechanism. Elevated SIRT1 in RA synovia suppresses TIMP1 expression via deacetylation of TIMP1-associated histones, thereby disrupting the binding of the transcription factor specificity protein 1 (Sp1) to the TIMP1 promoter. In rats with collagen-induced arthritis, depletion of SIRT1 remarkably promoted TIMP1 expression in synovial tissues and ameliorated cartilage destruction. These results describe a new role for SIRT1 and demonstrate its potential value as a therapeutic target for rheumatoid arthritis. Impact Journals LLC 2017-10-06 /pmc/articles/PMC5687661/ /pubmed/29179491 http://dx.doi.org/10.18632/oncotarget.21628 Text en Copyright: © 2017 Guo et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Guo, Jiangtao Zhao, Wei Cao, Xuqing Yang, Huiying Ding, Juan Ding, Jingbin Tan, Zifang Ma, Xiaoli Hao, Chunfang Wu, Lili Ma, Zhengjuan Xie, Jianjun Wang, Zhijun SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1 |
title | SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1 |
title_full | SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1 |
title_fullStr | SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1 |
title_full_unstemmed | SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1 |
title_short | SIRT1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting TIMP1 |
title_sort | sirt1 promotes tumor-like invasion of fibroblast-like synoviocytes in rheumatoid arthritis via targeting timp1 |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687661/ https://www.ncbi.nlm.nih.gov/pubmed/29179491 http://dx.doi.org/10.18632/oncotarget.21628 |
work_keys_str_mv | AT guojiangtao sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT zhaowei sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT caoxuqing sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT yanghuiying sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT dingjuan sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT dingjingbin sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT tanzifang sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT maxiaoli sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT haochunfang sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT wulili sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT mazhengjuan sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT xiejianjun sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 AT wangzhijun sirt1promotestumorlikeinvasionoffibroblastlikesynoviocytesinrheumatoidarthritisviatargetingtimp1 |